Genetec Corporation (TYO:4492)

Genetec Statistics

Total Valuation

Genetec has a market cap or net worth of JPY 5.70 billion. The enterprise value is 6.07 billion.

Market Cap	5.70B
Enterprise Value	6.07B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Genetec has 11.49 million shares outstanding. The number of shares has increased by 0.42% in one year.

Current Share Class	11.49M
Shares Outstanding	11.49M
Shares Change (YoY)	+0.42%
Shares Change (QoQ)	-3.06%
Owned by Insiders (%)	71.36%
Owned by Institutions (%)	n/a
Float	2.47M

Valuation Ratios

The trailing PE ratio is 14.96.

PE Ratio	14.96
Forward PE	n/a
PS Ratio	0.66
PB Ratio	2.47
P/TBV Ratio	5.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	15.71
EV / Sales	0.71
EV / EBITDA	8.45
EV / EBIT	10.83
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.99.

Current Ratio	1.38
Quick Ratio	1.18
Debt / Equity	0.99
Debt / EBITDA	3.18
Debt / FCF	n/a
Interest Coverage	35.00

Financial Efficiency

Return on equity (ROE) is 17.52% and return on invested capital (ROIC) is 9.20%.

Return on Equity (ROE)	17.52%
Return on Assets (ROA)	6.26%
Return on Invested Capital (ROIC)	9.20%
Return on Capital Employed (ROCE)	15.33%
Revenue Per Employee	13.89M
Profits Per Employee	623,586
Employee Count	619
Asset Turnover	1.54
Inventory Turnover	21.73

Taxes

In the past 12 months, Genetec has paid 176.00 million in taxes.

Income Tax	176.00M
Effective Tax Rate	31.32%

Stock Price Statistics

The stock price has decreased by -20.16% in the last 52 weeks. The beta is 0.62, so Genetec's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-20.16%
50-Day Moving Average	473.70
200-Day Moving Average	505.21
Relative Strength Index (RSI)	52.45
Average Volume (20 Days)	43,740

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genetec had revenue of JPY 8.60 billion and earned 386.00 million in profits. Earnings per share was 33.15.

Revenue	8.60B
Gross Profit	3.37B
Operating Income	560.00M
Pretax Income	562.00M
Net Income	386.00M
EBITDA	717.50M
EBIT	560.00M
Earnings Per Share (EPS)	33.15

Balance Sheet

The company has 1.92 billion in cash and 2.28 billion in debt, giving a net cash position of -364.00 million or -31.67 per share.

Cash & Cash Equivalents	1.92B
Total Debt	2.28B
Net Cash	-364.00M
Net Cash Per Share	-31.67
Equity (Book Value)	2.31B
Book Value Per Share	200.53
Working Capital	1.19B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 39.19%, with operating and profit margins of 6.51% and 4.49%.

Gross Margin	39.19%
Operating Margin	6.51%
Pretax Margin	6.54%
Profit Margin	4.49%
EBITDA Margin	8.35%
EBIT Margin	6.51%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 19.50, which amounts to a dividend yield of 3.97%.

Dividend Per Share	19.50
Dividend Yield	3.97%
Dividend Growth (YoY)	-20.00%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-0.42%
Shareholder Yield	3.55%
Earnings Yield	6.77%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 28, 2023. It was a forward split with a ratio of 3.

Last Split Date	Dec 28, 2023
Split Type	Forward
Split Ratio	3

Scores

Genetec has an Altman Z-Score of 2.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.9
Piotroski F-Score	2